NEW YORK, Oct. 17 (GenomeWeb News) - San Diego-based Diversa and Princeton, NJ-based Medarex yesterday announced they have entered into an R&D collaboration to develop and optimize antibodies to be used as drug targets.
A draft bill released by the US House of Representatives appropriations committee would increase the 2019 National Institutes of Health budget by 3 percent.
